Ruiz-Garcia Henry, Huayllani Maria T, Incontri Diego, Whaley Juan J, Marenco-Hillembrand Lina, Ebot James, Chaichana Kaisorn L, Sheehan Jason, Quiñones-Hinojosa Alfredo, Trifiletti Daniel M
Department of Radiation Oncology, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL, 32224, USA.
Department of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA.
J Neurooncol. 2020 Sep;149(2):283-292. doi: 10.1007/s11060-020-03603-8. Epub 2020 Sep 8.
Choroid plexus tumors (CPTs) represent one of the most common intraventricular tumors. Although most are benign, they often reach considerable sizes before clinical manifestation, challenging their surgical management. We aim to describe the clinical characteristics and the impact of current management on the survival of patients harboring intraventricular CPT.
The National Cancer Database (NCDB) was queried to identify biopsy-proven intraventricular CPT patients (2004-2015). Demographic and patterns of care were described, the log-rank method was used to independently analyze survival according to age, WHO grade and extent of resection (EOR). Multivariate analysis was performed to investigate the impact of prognostic factors on overall survival (OS).
A total of 439 CPT patients with known WHO grade were included. WHO grade I tumors were more frequent in adults, while WHO grade III tumors were more common in pediatric population. Most CPTs were benign, with a median tumor size of 3-4 cm. Mean tumor size in pediatric population was greater than in adult population (4.39 cm vs. 2.7 cm; p < 0.01). Frequency was similar between males and females (51.7% vs. 48.3%; p > 0.0.5). Five- and ten-year OS among all patients was 87% and 84%, respectively. EOR was not associated with survival for any WHO grade. On multivariable analysis, only patient age (p = 0.022), WHO grade (p = 0.003) and medical comorbidity scores (p = 0.002) were independently associated with OS after diagnosis.
Patients with CPTs present at different stages of life, with sizable tumor burden and distinct WHO grade prevalence. Considering their favorable survival, efforts to improve tumor control should be meticulously weighed against the long-term risk associated with surgery, radiation, and chemotherapy.
脉络丛肿瘤(CPTs)是最常见的脑室内肿瘤之一。尽管大多数为良性,但它们在临床表现之前往往已长得相当大,这对其手术治疗构成挑战。我们旨在描述脑室内CPT患者的临床特征以及当前治疗方法对其生存的影响。
查询国家癌症数据库(NCDB)以识别经活检证实的脑室内CPT患者(2004 - 2015年)。描述了人口统计学和治疗模式,采用对数秩检验方法根据年龄、世界卫生组织(WHO)分级和切除范围(EOR)独立分析生存率。进行多变量分析以研究预后因素对总生存期(OS)的影响。
共纳入439例已知WHO分级的CPT患者。WHO I级肿瘤在成人中更常见,而WHO III级肿瘤在儿童人群中更常见。大多数CPT为良性,肿瘤中位大小为3 - 4厘米。儿童人群的平均肿瘤大小大于成人人群(4.39厘米对2.7厘米;p < 0.01)。男性和女性的发病率相似(51.7%对48.3%;p > 0.05)。所有患者的5年和10年总生存率分别为87%和84%。对于任何WHO分级,EOR均与生存率无关。多变量分析显示,仅患者年龄(p = 0.022)、WHO分级(p = 0.003)和合并症评分(p = 0.002)与诊断后的总生存期独立相关。
CPT患者出现在生命的不同阶段,肿瘤负荷较大,WHO分级患病率各异。鉴于其良好的生存率,改善肿瘤控制的努力应与手术、放疗和化疗相关的长期风险进行审慎权衡。